Presenters: Iain MacGilp, Ph.D., Director, GMP Production, Curia Amber McFarlane, Head of Formulation Development, Curia Listen in as our experts discuss: The importance of an integrated formulation development and clinical supply function that can support accelerated timelines to clinic, including complex formulations Recent and ongoing experiences in liposomal formulations, with focus on high pressure homogenization Linearity of laboratory to clinical supply scale-up with supporting analytics Broad applicability to variety of product types and presentations (liquid, lyophilized, potent compounds, cytotoxicsView resource
More from Curia
The clinical value of biologics for the treatment of many disease indications has been accompanied by phenomenal sales. By 2026, the global market for biologics is projected to increase to $537 billion. However, getting a promising drug candidate fro...